This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

25 Jun 2012

BRIC Markets Account for 20-30Pc of Pharma Companies' Profits

Cegedim's latest report highlights strategies to boost growth in China and other emerging markets.

The emerging markets of Brazil, Russia, India and China (BRIC) are now responsible for a significant and ever-growing proportion of pharmaceutical companies' profits, a new report suggests.


Cegedim, a global technology and services company that specialises in the healthcare field, has published its latest report on the relationship between evolving BRIC countries and pharmaceutical markets.


The report, entitled 'Emerging Markets Today and Tomorrow: Insights on Healthcare, Pharmaceuticals and Future Trends in the BRIC Landscape', is based on insights from experts in all four BRIC markets and suggests the best strategies to boost growth in each country.


According to the report, BRIC markets now a

Related News